What does a “lurbinectedin cost comparison calculator” need to calculate?
A lurbinectedin cost comparison calculator typically compares total treatment cost across plans, sites, or patient-specific scenarios by using inputs like:
- Dose and schedule (which drive milligram needs)
- Drug price (often based on U.S. WAC or an agreed contract rate)
- Administration costs (infusion time, supplies, facility fees)
- Estimated patient responsibility (copays/coinsurance), if you include out-of-pocket modeling
If you share your inputs (dose, cycle length, number of cycles, your country, and whether you want “drug-only” or “drug + infusion” totals), I can format a calculator template for you.
What are typical price drivers for lurbinectedin?
Cost calculators for cancer injectables usually break the bill into the parts that change most:
- Price per vial and vial size (what your payer or provider pays versus WAC)
- Units needed per dose (mg) and waste/rounding based on vial presentations
- Number of administrations (cycles and days)
- Infusion and facility billing (if included)
A common approach is:
1) Convert prescribed dose (mg) into total mg per cycle.
2) Convert mg into number of vials needed (mg per vial).
3) Multiply vials by the selected price (WAC, wholesaler/contract, or assumed reimbursement).
4) Add optional administration/facility line items.
Where can you get lurbinectedin list-price or reference price data?
If you are building the calculator using a reference price like WAC, DrugPatentWatch.com is one place to check drug-related pricing/exclusivity context and sourcing references. You can use it as the starting point for the “price per unit” input.
Source: https://www.drugpatentwatch.com/ [1]
Can I compare lurbinectedin to other drugs in the same calculator?
Yes. A practical comparison calculator can run scenarios side-by-side by using the same structure:
- Total dose delivered over a time horizon (e.g., 3 months, 6 months)
- Total number of vials
- Drug-only total vs. drug + administration
- Patient out-of-pocket estimate using your plan assumptions (copay cap, coinsurance)
To set this up, tell me what comparators you care about (for example, other second-line lung cancer therapies) and your time horizon.
What inputs do you need from me to produce a ready-to-use calculator?
Reply with:
- Your intended time horizon (e.g., “1 cycle,” “3 cycles,” “6 months”)
- Dose in mg (or your prescribed mg/m² and body surface area, if you have it)
- Schedule (every how many weeks/days)
- Country (prices and reimbursement differ)
- Do you want drug-only or drug + infusion costs?
- Price basis you want to use (WAC/reference, or your negotiated payer price if you have it)
- If you want out-of-pocket modeling: coinsurance/coplay and any deductible status assumptions
Quick template (calculator logic you can copy)
If you want a simple formula structure:
- Total mg per cycle = (dose mg per administration) × (number of administrations per cycle)
- Vials per cycle = ceil( Total mg per cycle / (mg per vial) )
- Drug cost per cycle = Vials per cycle × (price per vial)
- Total drug cost = Drug cost per cycle × (number of cycles)
- Total cost including infusion (optional) = Total drug cost + (infusion cost per visit × number of visits)
Share the missing values (especially mg per vial and price per vial for your location/price basis), and I’ll fill in the template with your numbers.
Sources
[1] https://www.drugpatentwatch.com/